SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Temenos AG (TMSNY) trades at a trailing P/E of 23.5, forward P/E of 19.8. Trailing earnings yield is 4.26%, forward earnings yield 5.04%. PEG 0.36 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (23.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.36); earnings yield beats bond yields (4.26%).
- Forward P/E 19.8 (down from trailing 23.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.36 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.26% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.04% as earnings recover.
Overall SharesGrow Score: 77/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TMSNY
Valuation Multiples
P/E (TTM)23.5
Forward P/E19.8
PEG Ratio0.36
Forward PEG1.08
P/B Ratio0.00
P/S Ratio6.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.02
Forward EPS (Est.)$4.76
Book Value / Share$0.00
Revenue / Share$15.62
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.26%
Forward Earnings Yield5.04%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.61 |
$634.04M |
$115.83M |
18.3% |
| 2017 |
$1.90 |
$735.36M |
$138.41M |
18.8% |
| 2018 |
$2.31 |
$840.86M |
$168.23M |
20% |
| 2019 |
$2.46 |
$971.97M |
$181.12M |
18.6% |
| 2020 |
$2.39 |
$887.36M |
$175.02M |
19.7% |
| 2021 |
$2.40 |
$967M |
$173.37M |
17.9% |
| 2022 |
$1.59 |
$949.63M |
$114.42M |
12% |
| 2023 |
$1.85 |
$1B |
$134.68M |
13.5% |
| 2024 |
$2.43 |
$1.04B |
$177.18M |
17% |
| 2025 |
$4.02 |
$1.1B |
$282.04M |
25.7% |
